The benefits of using diverse animal models for studying pertussis

Trends in Microbiology

Volumn 15, Issue 10, 2007, Pages 462-468

  Elahi, Shokrollah ^a   Holmstrom, James ^a   Gerdts, Volker ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

BACTERIAL TRANSMISSION; BORDETELLA PERTUSSIS; BRONCHOPNEUMONIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DRUG EFFICACY; GUINEA PIG; HOST RESISTANCE; HUMAN; HYPOGLYCEMIA; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTOSIS; MARMOSET; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PERTUSSIS; PIGLET; PRIMATE; PRIORITY JOURNAL; PUPPY; RABBIT; RAT; REVIEW; RHESUS MONKEY; SINGLE DRUG DOSE;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DISEASE MODELS, ANIMAL; HUMANS; PERTUSSIS VACCINE; WHOOPING COUGH;

ANIMALIA; BORDETELLA PERTUSSIS;

EID: 35648965677     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2007.09.003     Document Type: Review

References (69)

1. WHO. Pertussis vaccines: W.H.O position paper. Wkly. Epidemiol. Rec. 74 (1999) 137-144
2. Tanaka M., et al. Trends in pertussis among infants in the United States, 1980-1999. J. Am. Med. Assoc. 290 (2003) 2968-2975
3. WHO (2000) Pertussis surveillance. In Global meeting; October 16-18 2000, World Health Organisation
4. Groseclose S.L., et al. Summary of notifiable diseases - United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 51 (2004) 1-84
5. Guiso N. Is Bordetella pertussis changing?. ASM News 71 (2005) 230-234
6. Standfast A.F. The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis. Immunology 1 (1958) 135-143
7. Musser J.M., et al. Genetic diversity and relationships in populations of Bordetella spp. J. Bacteriol. 166 (1986) 230-237
8. Pittman M., et al. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J. Infect. Dis. 142 (1980) 56-66
9. Elahi S., et al. Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect. Immun. 73 (2005) 3636-3645
10. Mallory F.B., and Horner A.A. Pertussis: the histological lesion in the respiratory tract. J. Med. Res. 27 (1912) 115-123
11. Weiss A.A., and Hewlett E.L. Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40 (1986) 661-686
12. Inaba I., and Inamori S. Blood picture in experimental whooping cough. Am. J. Dis. Child. 48 (1934) 1193-1200
13. Sato Y., and Sato H. Animal models of pertussis. In: Wardlaw A.C., and Parton R. (Eds). Pathogenesis and immunity in pertussis (1988), John Wiley & Sons Ltd 309-326
14. Woods D.E., et al. Development of a rat model for respiratory infection with Bordetella pertussis. Infect. Immun. 57 (1989) 1018-1024
15. Preston N.W., et al. Experimental pertussis infection in the rabbit: similarities with infection in primates. J. Infect. 2 (1980) 227-235
16. Sprunt D.H., et al. Results of the intratracheal injection of the Bordet-Gengou bacillus in the monkey and rabbit. J. Exp. Med. 67 (1938) 309-321
17. MacDonald H., and MacDonald E.J. Experimental pertussis. J. Infect. Dis. 53 (1933) 328-330
18. Sato H., and Sato Y. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis. Dev. Biol. Stand. 61 (1985) 461-467
19. Mills K.H., et al. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity. Dev. Biol. Stand. 95 (1998) 31-41
20. Proom H. The immunological aspects of experimental haemophilus pertussis infection. J. Pathol. Bacteriol. 59 (1947) 165-180
21. Halperin S.A., et al. Experimental respiratory infection with Bordetella pertussis in mice: comparison of two methods. Clin. Invest. Med. 11 (1988) 297-303
22. Sato Y., et al. Aerosol infection of mice with Bordetella pertussis. Infect. Immun. 29 (1980) 261-266
23. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18 (2005) 326-382
24. Huang C.C., et al. Experimental Whooping cough. N. Engl. J. Med. 266 (1962) 105-111
25. Shahin R.D., and Cowell J.L. Mouse respiratory infection models for pertussis. Methods Enzymol. 235 (1994) 47-58
26. Linnemann Jr. C.C., et al. Pertussis: persistent problems. J. Pediatr. 85 (1974) 589-591
27. Guiso N., et al. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17 (1999) 2366-2376
28. Denoel P., et al. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. Vaccine 23 (2005) 5333-5341
29. Watanabe M., and Nagai M. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect. Immun. 71 (2003) 733-738
30. Hodge G., et al. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained?. Respirology 8 (2003) 157-162
31. Heininger U., et al. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics 100 (1997) E10
32. Klimenko W. Centralbl. f. Bakt. Abt. I. Originale 48 (1908) 64-76
33. Reisine T. Pertussis toxin in the analysis of receptor mechanisms. Biochem. Pharmacol. 39 (1990) 1499-1504
34. Munoz J.J., et al. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect. Immun. 33 (1981) 820-826
35. Morse S.I., and Morse J.H. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J. Exp. Med. 143 (1976) 1483-1502
36. Lawson G.M. Studies on Bacillus pertussis. Harvard School Public Health (1932), Harvard
37. Smith L.W. The pathologic anatomy of pertussis. Arch. Pathol. Lab. Med. 4 (1927) 732-742
38. Vandebriel R.J., et al. Association of Bordetella pertussis with host immune cells in the mouse lung. Microb. Pathog. 35 (2003) 19-29
39. Mills K.H., et al. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61 (1993) 399-410
40. Mills K.H. Immunity to Bordetella pertussis. Microbes Infect. 3 (2001) 655-677
41. von Konig C.H., et al. Pertussis of adults and infants. Lancet Infect. Dis. 2 (2002) 744-750
42. Shahin R.D., et al. Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Infect. Immun. 62 (1994) 722-725
43. Halperin S.A., et al. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin. J. Infect. Dis. 163 (1991) 355-361
44. Leef M., et al. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J. Exp. Med. 191 (2000) 1841-1852
45. Greco D., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 334 (1996) 341-348
46. Gustafsson L., et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334 (1996) 349-355
47. Ryan M., et al. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175 (1997) 1246-1250
48. Barbic J., et al. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect. Immun. 65 (1997) 4904-4908
49. Mahon B.P., et al. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J. Exp. Med. 186 (1997) 1843-1851
50. Byrne P., et al. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34 (2004) 2579-2588
51. Higgins S.C., et al. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171 (2003) 3119-3127
52. Higgins S.C., et al. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177 (2006) 7980-7989
53. Redhead K., et al. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61 (1993) 3190-3198
54. Kirimanjeswara G.S., et al. The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J. Immunol. 175 (2005) 7504-7511
55. Mann P.B., et al. Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J. Infect. Dis. 189 (2004) 833-836
56. Mills, K.H. et al. (2006) Bordetella pertussis, immunity versus immune subversion. In Eighth International Symposium Saga of the genys Bordetella
57. Carbonetti N.H. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr. Opin. Pharmacol. 7 (2007) 272-278
58. Kelly M.N., et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73 (2005) 617-621
59. Xing D.K., et al. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo. Vaccine 18 (2000) 2110-2119
60. Canthaboo C., et al. Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge. Infect. Immun. 70 (2002) 679-684
61. Bals R., and Hiemstra P.S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23 (2004) 327-333
62. Schaeffer L.M., et al. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J. Immunol. 173 (2004) 1959-1965
63. Schaeffer L.M., et al. Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella spertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect. Immun. 72 (2004) 7124-7130
64. Elahi S., et al. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect. Immun. 74 (2006) 2338-2352
65. Mills K.H., et al. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66 (1998) 594-602
66. Lichty J.R., et al. Attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy. J. Clin. Invest. 17 (1938) 613-621
67. Gonik B., et al. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect. Dis. Obstet. Gynecol. 13 (2005) 59-61
68. Oda M., et al. Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. J. Infect. Dis. 148 (1983) 138-145
69. Elahi S., et al. Maternal immunity provides protection against pertussis in newborn piglets. Infect. Immun. 74 (2006) 2619-2627